Page last updated: 2024-12-05
domiphen
Description
Domiphen bromide is a quaternary ammonium compound that is used as an antiseptic and disinfectant. It is a cationic surfactant and has a long history of use in medical and veterinary settings. Domiphen bromide is effective against a wide range of bacteria, fungi, and viruses. It is also effective against some parasites, such as mites and lice. Domiphen bromide is typically used in topical applications, such as skin washes, wound care products, and antiseptic mouthwashes. It is also used in some veterinary products, such as disinfectants and antiseptics for animals. Domiphen bromide is generally well-tolerated, but some individuals may experience mild skin irritation or allergic reactions. It is important to note that domiphen bromide is not effective against all bacteria, fungi, or viruses, and it should not be used to treat serious infections. '
domiphen: RN given refers to bromide; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 3149 |
| CHEMBL ID | 1187011 |
| CHEBI ID | 135978 |
| SCHEMBL ID | 1702653 |
| MeSH ID | M0050825 |
Synonyms (31)
| Synonym |
|---|
| dodecyl-dimethyl-(2-phenoxyethyl)azanium |
| CHEBI:135978 |
| domiphen |
| dodecyl-dimethyl-(2-phenoxyethyl)azanium bromide |
| yxupzgkorwtxid-uhfffaoysa- |
| inchi=1/c22h40no/c1-4-5-6-7-8-9-10-11-12-16-19-23(2,3)20-21-24-22-17-14-13-15-18-22/h13-15,17-18h,4-12,16,19-21h2,1-3h3/q+1 |
| NCGC00091010-05 |
| NCGC00091010-02 |
| NCGC00091010-04 |
| CHEMBL1187011 |
| unii-4azl56cu0f |
| 4azl56cu0f , |
| 13900-14-6 |
| dodecyldimethyl(2-phenoxyethyl)ammonium |
| n,n-dimethyl-n-(2-phenoxyethyl)dodecan-1-aminium |
| STL257462 |
| dodecyl-dimethyl-(2-phenoxyethyl)ammonium |
| domiphen ion |
| phenododecinium |
| domiphen [vandf] |
| domiphen cation |
| (.beta.-phenoxyethyl)dimethyldodecylammonium |
| domiphen [who-dd] |
| 1-dodecanaminium, n,n-dimethyl-n-(2-phenoxyethyl) |
| AKOS022105914 |
| DTXSID2048080 |
| SCHEMBL1702653 |
| AB01566921_01 |
| (beta-phenoxyethyl)dimethyldodecylammonium |
| DB11594 |
| Q27098012 |
Drug Classes (1)
| Class | Description |
|---|
| aromatic ether | Any ether in which the oxygen is attached to at least one aryl substituent. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (12)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 43.01
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 43.01 (24.57) | | Research Supply Index | 2.94 (2.92) | | Research Growth Index | 5.16 (4.65) | | Search Engine Demand Index | 61.57 (26.88) | | Search Engine Supply Index | 2.10 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 4 (28.57%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (71.43%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |